H. Defacque et al., EXPRESSION OF RETINOID-X RECEPTOR A IS INCREASED UPON MONOCYTIC CELL-DIFFERENTIATION, Biochemical and biophysical research communications, 220(2), 1996, pp. 315-322
1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic
differentiation of both normal and leukemic cells. Its effects are med
iated by its nuclear receptor (VDR). Efficient gene activation require
s the heterodimerization of VDR with Retinoid X Receptors (RXR). In th
e present study using specific antibodies, we analyzed the expression
of the RXR alpha protein in blood mononuclear cells from acute myeloid
patients (AML) (10 cases) and from myelomonocytic cell lines arrested
at different stages of differentiation. We observed that the RXR alph
a expression increased during myelomonocytic differentiation, since th
e highest levels were found in AML samples and in myelomonocytic cell
lines having the highest amounts of monocytic precursors. We also demo
nstrated that fresh leukemic cells, whatever their stage of differenti
ation, as well as myelomonocytic cell lines, respond to VD by an incre
ase in RXR alpha levels. Combinations of all-trans retinoic acid (RA)
and VD, in some cases, increased this effect. This response suggests t
he involvement of RXR alpha in monocytic differentiation upon VD treat
ment. (C) 1996 Academic Press, Inc.